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Background: Few studies have investigated the relationship between anemia, smoking, drinking and survival in
esophageal squamous cell carcinoma (ESCC) with primary radiotherapy. This study had the aim of evaluating the
prognostic value of anemia, smoking and drinking in patients receiving primary radiotherapy for ESCC.
Methods: A total of 79 patients who underwent radiotherapy during initial treatment for ESCC were included in
this study. The 2-year overall survival (OS) and disease-free survival (DFS) were analyzed between the anemic and
non-anemic groups, non-smokers and smokers, and non-drinkers and drinkers using the Kaplan-Meier method and
the Cox proportional hazards model.
Results: There were 79 patients (10 male) of median age 63 (range 38 to 84) years. The 2-year OS and DFS were
36% and 25%, respectively, in the non-anemic group, and 17% and 13%, respectively, in the anemic group
(P = 0.019 for OS; P = 0.029 for DFS) using the Kaplan-Meier method. Survival analysis using the Kaplan-Meier
method showed that the 2-year OS and DFS had no statistical difference between smoking, drinking and
survival. In a univariate analysis, anemia was identified as a significant prognostic factor for 2-year OS (hazard
ratio (HR) = 1.897; P = 0.024) and 2-year DFS (HR = 1.776; P = 0.036), independent of tumor, lymph node,
metastasis (TNM) stage. In a multivariate analysis, anemia was identified as a highly significant prognostic factor
for 2-year OS (HR = 2.125; P = 0.011) and 2-year DFS (HR = 1.898; P = 0.025), independent of TNM stage and
initial treatment. We found no statistical difference in the 2-year OS and DFS associated with smoking (P > 0.2)
and drinking (P > 0.6) using univariate and multivariate analysis.
Conclusions: Smoking and drinking were not prognostic for 2-year OS or DFS. Anemia before radiotherapy was
associated with poor prognosis and an increased risk of relapse, which may serve as a new prognostic
characteristic in ESCC treated with primary radiotherapy. Hemoglobin is a routine examination and anemia is
therefore simple and quick to determine.
Keywords: Anemia, Survival, Smoking, Drinking, Squamous cell carcinoma, Esophageal neoplasms* Correspondence: qilucyf@126.com
1Department of Radiotherapy, Cancer Centre, Qilu Hospital, Shandong
University, 107 Wenhuaxi Rd, Jinan, Shandong 250012, China
Full list of author information is available at the end of the article
© 2013 Zhang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zhang et al. World Journal of Surgical Oncology 2013, 11:249 Page 2 of 6
http://www.wjso.com/content/11/1/249Background
Esophageal cancer is the eighth most common cancer
and the sixth most common cause of mortality in the
world [1]. The distribution of esophageal cancer is
heterogenous. Developed countries (except for Japan)
have low rates, while China has a high rate of esophageal
cancer, the fourth most common cause of mortality
in China [2,3]. Esophageal squamous cell carcinoma
(ESCC) continues to be the major type of esophageal
cancer in Asia; in contrast, esophageal adenocarcinoma
predominately affects the whites. Tobacco smoking and
alcohol are well established causes of ESCC; however,
there are few reports that directly evaluate these factors
as prognostic factors for esophageal cancer.
Anemia is known to produce tumor hypoxia which
confers radio-resistance through the hypoxia-associated
reduction in free-radical production and consequent
radiotherapy-induced DNA damage [4]. Fein and col-
leagues reported that the 2-year local control rates in
the non-anemic group were significantly better than
those in the anemic group (P < 0.0018) in T1-T2 squa-
mous cell carcinoma of the glottic larynx [5]. However,
few studies have investigated the relation between
anemia and survival in patients with ESCC.
The objective of this study was to evaluate the prog-
nostic value of anemia, smoking and drinking in patients
receiving primary radiotherapy for ESCC and its rela-
tionship with other prognostic factors.
Methods
Patients
From the database of the Qilu Hospital of Shandong
University, we selected all patients with ESCC who
underwent radiotherapy during initial treatment at the
Department of Radiation Oncology of the Qilu Hospital
from 1 January 2009 to 31 December 2010. All patients
who did not undergo operation in this study were staged
according to routine practice of our hospital with air
contrast barium esophagography, upper gastrointestinal
endoscopy with histological biopsies and cervical, chest
and abdominal contrast computed tomography. All
patients who underwent operation in this study were
staged according to the American Joint Committee on
Cancer TNM staging system [6]. All patients had intended
curative radiation therapy alone or pre- or post-operative
radiotherapy or radiochemotherapy according to the prac-
tice. Radiotherapy was started on day 1 and delivered at 2
Gy/day for 5 days a week for a total radiation dose of 66 to
72 Gy for those without operation and a total radiation
dose of 50 Gy for those with operation. Patients without
recorded hemoglobin levels were excluded, as were patients
who died during radiotherapy. Patient, tumor, and treat-
ment characteristics were retrieved from the Medical Re-
cords Room. All patients signed informed consent to thisstudy, and the protocol was approved by the Ethics
Committee of Qilu Hospital of Shandong University.
Definition of anemia
The definition of anemia used in this study was kept
consistent with the definitions used by our laboratory: a
hemoglobin level under 12 g/dL for men and under 11
g/dL for women. A hemoglobin level of 9 to 12 g/dL for
men and 9 to 11 g/dL for women was defined as mild
anemia, and a hemoglobin level of 6 to 9 g/dL for both
men and women as moderate anemia. A patient was
classified as being anemic if their hemoglobin measured
before radiotherapy met these levels. During this study
the ‘before-radiotherapy’ was defined as 4 weeks prior to
receiving radiotherapy.
Follow-up
Follow-up data were collected until death or 31 Decem-
ber 2012. All patients had a regular follow-up schedule
including a complete history and physical examination
every 3 months during the first 2 years, every 6 months
during the first 3 to 5 years and every year thereafter.
Routine radiological examinations were performed when
necessary.
Statistical analysis
Differences in patient, tumor, and treatment characteris-
tics were assessed using the Mann–Whitney test for
continuous variables and the χ2 test for categorical vari-
ables. The Kaplan-Meier method and log-rank test were
used for analysis and comparison of survival curves. For
the analysis of 2-year overall survival (OS), events were
defined as death from any cause. For the analysis of
2-year disease-free survival (DFS), events were defined
as first loco-regional or distant tumor relapse or death
from any cause. The Cox proportional hazards model
was used to determine the hazard ratio (HR) of variables
on 2-year OS and DFS in univariate and multivariate
analysis. The results are given as HRs with their 95%
confidence interval (CI). P values less than 0.05 were
considered statistically significant. Data were analyzed
using the statistical package SPSS version 17.0 (SPSS
Inc., Chicago, IL, USA).
Results
The prevalence of anemia, smoking and drinking
There were 23 anemic patients from the total of 79
patients; 20 patients with mild anemia, and 3 with mod-
erate anemia. The median hemoglobin levels were 13.8
g/dL (11.8 to 16.9) in the non-anemic group and 10.6
g/dL (8.3 to 11.9) in the anemic group. The prevalence
of anemia in patients undergoing radiotherapy was
29.1%. Of the 79 patients, 33 patients (41.8%) were non-
smokers, whereas 46 patients (58.2%) were smokers. Of
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whereas 46 patients (50.6%) were drinkers.
Clinicopathological features
All patients (69 men and 10 women) were included in
this study. The median age of the patients was 63 (range
38 to 84) years at the date diagnosed. The median sur-
vival time was 19 (2 to 56) months. Characteristics of
the patients are shown in Table 1.
Correlation of anemia with other prognostic factors
Table 1 shows patient characteristics for the non-anemic
and the anemic groups. There were no significant differ-
ences between the two groups. Follow up was complete.
The 2-year OS and DFS were 36% and 25%, respectively,
in the non-anemic group, and 17% and 13%, respect-
ively, in the anemic group. Both 2-year OS and DFS in
the non-anemic group were significantly better than
those in the anemic group (P = 0.019 for OS; P = 0.029
for DFS) using the Kaplan-Meier method. Survival
curves are shown in Figure 1.
In the Cox univariate model, anemia and tumor, lymph
node, metastasis (TNM) stage were significantly related
to 2-year OS (HR = 1.897, 95% CI 1.086 to 3.312;






















TNM, tumor, lymph node, metastasis.P = 0.036), respectively. Anemia before radiotherapy was
associated with poor prognosis and an increased risk of
relapse (Table 2). In a multivariate analysis, anemia was
identified as a highly significant prognostic factor for 2-
year OS (HR = 2.125; P = 0.011) and 2-year DFS (HR =
1.898; P = 0.025), independent of TNM stage and initial
treatment (Table 3).Correlation of smoking and drinking with other
prognostic factors
Follow-up was complete. Survival analysis using the
Kaplan-Meier method showed that there were no signifi-
cant differences in the 2-year OS and DFS between non-
smokers and smokers (P = 0.658 for OS; P = 0.939 for
DFS) and non-drinkers and drinkers (P = 0.819 for OS;
P = 0.866 for DFS). Using univariate and multivariate
analysis, there were no statistical differences on survival
between the non-smokers and the smokers, and between
the non-drinkers and drinkers (Tables 2 and 3).Discussion
In this study, the prevalence of anemia in patients with
ESCC undergoing primary radiotherapy was 29.1%.
Similarly, Walter and colleagues [7] reported that then-anaemic groups
Anemic Non-anemic P value
63 (40–76) 63 (38–84) 0.393
18 51 0.145
5 5
10. 5 (8.3-11.9) 13.7 (12.0-16.9) 0.000

















Figure 1 Kaplan-Meier curves for survival of 79 patients with esophageal squamous cell carcinoma (non-anemic versus anemic). Both
2-year overall survival (A) and disease-free survival (B) between two groups remained statistically significant.
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radiotherapy was 35%.
Recently, much research has shown that anemia was
associated with poor prognosis and an increased risk of
relapse. Dietl and colleagues [8] reported that anemia
was an independent negative prognostic factor for
local recurrence-free survival and overall survival in pa-
tients with head and neck cancer treated with surgery
and postoperative radiotherapy. Furthermore, moderate
anemia was also confirmed as an independent prognos-
tic factor in squamous cell carcinoma of the head and
neck treated with radiotherapy alone [9]. Grigiene and
colleagues [10] found that the hemoglobin level before
treatment was an independent prognostic factor for OS,
DFS and local relapse-free survival for patients with
uterine cervical carcinoma treated with irradiation using
univariate and multivariate analysis. In addition, MacRae
and colleagues [11] revealed that a decline in hemoglobin
during chemoradiation for stage III non-small cell lung
cancer had a statistically significant correlation with OS.
The present investigation shows that anemia is a new
independent prognostic factor for esophageal carcinoma.
We found that the 2-year OS and DFS were 36% andTable 2 Cox univariate analysis for 2-year survival in 79 patie
2-year ove
HR 95
Hemoglobin (non-anemic vs anemic) 1.897 1.086
Smoking (no vs yes) 0.889 0.522
Drinking (no vs yes) 0.941 0.554
TNM stage (I vs II vs III vs IV) 1.652 1.175
Initial treatment (RT vs S + RT vs CRT vs S + CRT) 0.840 0.655
Tumor location (C vs U vs M vs L) 0.937 0.703
C, cervical; CI, confidence interval; CRT, chemoradiotherapy; HR, hazard ratio; L, low
U, upper; vs, versus.25%, respectively, in the non-anemic group, and 17%
and 13%, respectively, in the anemic group (P = 0.019
for OS; P = 0.029 for DFS) using the Kaplan-Meier
method. Both 2-year OS and DFS in the non-anemic
group were significantly better than those in the anemic
group. In a multivariate analysis, anemia was identified
as a highly significant prognostic factor for 2-year OS
and 2-year DFS, independent of TNM stage and initial
treatment. Zenda and colleagues [12] concluded that the
pre-chemoradiotherapy hemoglobin level may be an im-
portant determinant of outcome in patients with T4/M1
LYM squamous cell carcinoma of the esophagus. This
result was consistent with previous studies regarding
anemia. Zhao and colleagues [13] revealed that anemia
resulted in a statistically significant reduction in OS and
DFS for patients with locally advanced esophageal car-
cinoma undergoing irradiation. In addition, Hofheinz
and colleagues [14] reported that a significant decrease
in hemoglobin levels during primary chemoradiotherapy
was identified as a prognostic factor for ESCC.
Smoking has long been known to be a major risk fac-
tor for ESCC, but little is known about the possible in-
fluence of the risk factor on survival. In our currentnts
Univariate analysis
rall survival 2-year disease-free survival
% CI P HR 95% CI P
-3.312 0.024 1.776 1.040-3.033 0.036
-1.514 0.666 0.981 0.593-1.622 0.940
-1.600 0.824 0.959 0.582-1.579 0.869
-2.322 0.004 1.650 1.193-2.281 0.002
-1.077 0.169 0.900 0.718-1.129 0.362
-1.250 0.660 0.964 0.736-1.263 0.792
; M, middle; RT, radiotherapy; S, surgery; TNM, tumor, lymph node, metastasis;
Table 3 Cox multivariate analysis for 2-year survival in 79 patients
Multivariate analysis
2-year overall survival 2-year disease-free survival
HR 95% CI P HR 95% CI P
Hemoglobin (non-anemic vs anemic) 2.125 1.190-3.796 0.011 1.898 1.085-3.320 0.025
Smoking (no vs yes) 0.623 0.286-1.359 0.235 0.746 0.370-1.503 0.412
Drinking (no vs yes) 1.208 0.559-2.611 0.631 1.170 0.581-2.354 0.660
TNM stage (I vs II vs III vs IV) 1.722 1.231-2.409 0.001 1.653 1.205-2.267 0.002
Initial treatment(RT vs S + RT vs CRT vs S + CRT) 0.732 0.561-0.956 0.022 0.812 0.640-1.032 0.088
CI, confidence interval; CRT, chemoradiotherapy; HR, hazard ratio; RT, radiotherapy; S, surgery; TNM, tumor, lymph node, metastasis; vs, versus.
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between smoking and OS or DFS in ESCC treated with
primary radiotherapy using the Kaplan-Meier method
(P > 0.6). Using univariate and multivariate analysis, our
data fail to demonstrate a link with smoking and 2-year
OS or DFS for patients with ESCC treated with primary
radiotherapy (P > 0.2). There have been some similar
studies published. In a series of 135 patients, Kandaz
and colleagues [15] found no statistical difference on
survival based on smoking in 135 patients with locally
advanced cancer of the esophagus treated with radio-
therapy and/or chemoradiotherapy. Michalek and col-
leagues [16] analyzed the outcome of 302 patients with
bladder cancer and showed that smoking status was not
associated with either recurrence-free survival or the
number of tumor recurrences. These findings suggest
that cigarette smoking is not an important prognostic
factor for patients with bladder cancer. The prognostic
significance of smoking was analyzed in 242 incident
cases of breast cancer from Norwegian women. Again,
there was no statistical difference on survival [17].
Drinking has been identified as a major risk factor for
esophageal cancer, but the effect on survival is unknown.
A study in esophageal carcinoma and cardia adenocar-
cinoma suggested that there were no statistically signifi-
cant associations between alcohol consumption and
prognosis [18]. Samadi and colleagues [19] reported that
drinking did not show any significant effects on the sur-
vival rate of patients with gastric and esophageal cancers
using the univariate and multivariate analysis. Similarly,
our data fail to demonstrate a link between drinking and
OS or DFS in patients with ESCC treated with primary
radiotherapy.
In our study, we did not show that smoking and drink-
ing were associated with survival in patients with ESCC
treated with primary radiotherapy. Trivers and col-
leagues [20] found that cigarette smoking and alcohol
intake did not predict survival of patients with esopha-
geal or gastric cancers. Furthermore, Tsai and colleagues
[21] analyzed 797 young patients with esophageal cancer
that received esophagectomy and found that there wasno statistical difference between smoking, drinking and
survival.
Many prognostic factors have been found for esopha-
geal cancer, such as TNM stage, tumor location, and
depth of tumor invasion. In this study, we found that
TNM stage was significantly related to 2-year OS and
DFS using univariate analysis. This result was consistent
with a previous study of 797 patients with esophageal
cancer who received esophagectomy [21]. For 2-year OS,
TNM stage and initial treatment were independent
prognostic factors, while, for 2-year DFS, TNM stage
was an independent prognostic factor using multivariate
analysis. Our results were similar to those of previous
studies [13,22,23].
Conclusion
In summary, we found that smoking and drinking were
not prognostic factors for 2-year OS or DFS. Our find-
ings indicate that anemia before radiotherapy is a new
prognostic factor for ESCC with primary radiotherapy,
independent of other prognostic factors. In addition,
hemoglobin is a routine examination, and so anemia can
be easily assessed. Further research with larger sample
sizes are needed to validate these findings.
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